Immunomodulatory effect of a nutraceutical mixture in a mouse model of metabolic syndrome

dc.audience.educationlevelPúblico en general/General publices_MX
dc.contributor.advisorSerna Saldívar, Sergio Román Othón
dc.contributor.authorGastélum Estrada, Alejandro
dc.contributor.catalogerpuelquioes_MX
dc.contributor.committeememberSantacruz López, Yolanda Arlette
dc.contributor.departmentSchool of Engineering and Scienceses_MX
dc.contributor.institutionCampus Monterreyes_MX
dc.contributor.mentorCanales Aguirre, Alejandro Arturo
dc.date.accepted2021-06
dc.date.accessioned2023-07-13T22:45:30Z
dc.date.available2023-07-13T22:45:30Z
dc.date.created2021
dc.date.issued2021-05-28
dc.descriptionCVU 3598es_MX
dc.descriptionhttps://orcid.org/0000-0002-9713-2928es_MX
dc.description.abstractCOVID-19 has impacted global community since its appearance in December 2019, with consequences in health, economic, employment, among many others that have created scenarios known as “new normality”. Along pharmacological measures, preventive ones have also been proposed including the change of diet patterns, increasing physical activities and others. In this work, nutraceuticals are explored for assessing their potential as COVID-19 preventers that could extrapolate to other new diseases or pandemics. Specifically, a nutraceutical mixture was tested in C57BL/6J mice, which is a model for obesity and metabolic syndrome, to evaluate immunomodulation potential by measuring the effect on blood indicators and immune biomarkers. Nutraceuticals evaluated include vitamins (C, D and E), minerals (selenium and zinc) and other ingredients as coenzyme Q10, microencapsulated probiotics, broccoli sprout powder and black bean coat flour as sources of sulforaphane and flavonoids, respectively. All of them have been widely studied and attributed with immunomodulatory properties, each one of them are explained and detailed in the second chapter. Results of blood indicators show a low effect on blood cells concentration and lipid profile, with no consistent differences between male and female individuals. No significant effect was determined in coagulation time. Some of the observed changes such as increase of erythrocytes and leukocyte in males of the supplemented group may suggest a heterogeneous effect between male and female mice, but more studies would be needed. While no significant effects were observed in lymphocyte-T analysis, the most relevant result was obtained in IL-1 evaluation, which level significantly increased in the obese-no supplemented group in comparison with the healthy group, but the increase was countered and even got to lower levels compared to healthy mice when the nutraceutical supplement was included in the diet. This result may suggest a higher effect of the nutraceuticals in inflammation processes rather than in blood cell levels.es_MX
dc.description.degreeMaestro en Ciencias con Especialidad en Biotecnologíaes_MX
dc.format.mediumTextoes_MX
dc.identificator7||33||3399||339999es_MX
dc.identifier.citationGastélum-Estrada, A. (2021). Immunomodulatory effect of a nutraceutical mixture in a mouse model of metabolic syndrome. Instituto Tecnológico y de Estudios Superiores de Monterrey.es_MX
dc.identifier.cvu1006849es_MX
dc.identifier.orcidhttps://orcid.org/0009-0003-4583-587Xes_MX
dc.identifier.urihttps://hdl.handle.net/11285/651029
dc.language.isoenges_MX
dc.publisherInstituto Tecnológico y de Estudios Superiores de Monterreyes_MX
dc.relation.isFormatOfpublishedVersiones_MX
dc.rightsopenAccesses_MX
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0es_MX
dc.subject.classificationINGENIERÍA Y TECNOLOGÍA::CIENCIAS TECNOLÓGICAS::OTRAS ESPECIALIDADES TECNOLÓGICAS::OTRASes_MX
dc.subject.keywordNutraceuticalses_MX
dc.subject.keywordImmunomodulationes_MX
dc.subject.keywordinterleukin 1es_MX
dc.subject.keywordInflammationes_MX
dc.subject.keywordCOVID-19es_MX
dc.subject.lcshSciencees_MX
dc.titleImmunomodulatory effect of a nutraceutical mixture in a mouse model of metabolic syndromees_MX
dc.typeTesis de maestría

Files

Original bundle

Now showing 1 - 4 of 4
Loading...
Thumbnail Image
Name:
Tesis_Maestría_ Alejandro Gastélum.pdf
Size:
2.53 MB
Format:
Adobe Portable Document Format
Description:
Tesis de Maestría PDF
Loading...
Thumbnail Image
Name:
CartaAutorizacionTesis-CON.pdf
Size:
106.47 KB
Format:
Adobe Portable Document Format
Description:
Declaración de Acuerdo para Uso de Obra
Loading...
Thumbnail Image
Name:
Caratula - MBI - Alejandro Gastelum_10jun21.pdf
Size:
168.43 KB
Format:
Adobe Portable Document Format
Description:
Hoja de Firmas
Loading...
Thumbnail Image
Name:
Autoría_ Alejandro Gastélum.pdf
Size:
340.41 KB
Format:
Adobe Portable Document Format
Description:
Carta autoría

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.3 KB
Format:
Item-specific license agreed upon to submission
Description:
logo

El usuario tiene la obligación de utilizar los servicios y contenidos proporcionados por la Universidad, en particular, los impresos y recursos electrónicos, de conformidad con la legislación vigente y los principios de buena fe y en general usos aceptados, sin contravenir con su realización el orden público, especialmente, en el caso en que, para el adecuado desempeño de su actividad, necesita reproducir, distribuir, comunicar y/o poner a disposición, fragmentos de obras impresas o susceptibles de estar en formato analógico o digital, ya sea en soporte papel o electrónico. Ley 23/2006, de 7 de julio, por la que se modifica el texto revisado de la Ley de Propiedad Intelectual, aprobado

DSpace software copyright © 2002-2025

Licencia